ProfileGDS2971 / 2.1.3.2
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 29% 21% 2% 32% 72% 55% 82% 5% 83% 69% 42% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.27655929
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.41505621
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-2.010572
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.26120932
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.29032972
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.029318655
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.65381382
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-2.459535
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.68854583
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.46347169
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.089085342
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.10067439